Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 17.40%39.34B | -8.96%33.51B | -2.36%9.2B | -20.94%7.94B | 28.68%9.41B | -30.59%6.96B | 24.54%36.8B | -20.73%9.42B | 76.11%10.05B | 16.35%7.31B |
| Cost of revenue | 19.02%30.35B | -10.04%25.5B | -11.94%7.28B | -8.17%5.98B | 34.93%7.2B | -38.78%5.04B | 20.20%28.35B | -20.54%8.27B | 54.09%6.51B | 11.47%5.34B |
| Gross profit | 12.25%8.99B | -5.33%8.01B | 66.52%1.92B | -44.49%1.96B | 11.87%2.21B | 6.83%1.92B | 41.73%8.46B | -22.03%1.15B | 138.92%3.54B | 31.93%1.97B |
| Operating expense | -1.07%3.33B | 13.11%3.37B | 26.54%1.15B | 6.24%749M | 6.70%748M | 8.77%719M | 9.66%2.98B | 7.46%908M | 15.38%705M | 11.45%701M |
| Staff costs | -0.30%1.67B | 16.59%1.67B | ---- | ---- | ---- | ---- | 10.81%1.44B | ---- | ---- | ---- |
| Depreciation and amortization | 14.07%154M | -6.90%135M | ---- | ---- | ---- | ---- | -13.69%145M | ---- | ---- | ---- |
| -Depreciation | 14.07%154M | -6.90%135M | ---- | ---- | ---- | ---- | -13.69%145M | ---- | ---- | ---- |
| Rent and land expenses | 2.10%146M | 27.68%143M | ---- | ---- | ---- | ---- | 8.74%112M | ---- | ---- | ---- |
| Other operating expenses | -3.75%1.36B | 10.21%1.41B | ---- | ---- | ---- | ---- | 11.86%1.28B | ---- | ---- | ---- |
| Operating profit | 21.91%5.66B | -15.34%4.64B | 216.53%766M | -57.12%1.21B | 14.72%1.46B | 5.71%1.2B | 68.47%5.48B | -61.59%242M | 225.78%2.83B | 46.82%1.27B |
| Net non-operating interest income (expenses) | -45.83%-140M | -24.68%-96M | 31.58%-13M | 5.88%-16M | -127.27%-50M | 10.53%-17M | -35.09%-77M | -35.71%-19M | -21.43%-17M | -46.67%-22M |
| Non-operating interest income | 66.67%5M | --3M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Non-operating interest expense | 33.85%87M | -15.58%65M | -15.79%16M | -5.88%16M | -27.27%16M | -10.53%17M | 35.09%77M | 35.71%19M | 21.43%17M | 46.67%22M |
| Total other finance cost | 70.59%58M | --34M | --0 | --0 | ---- | ---- | ---- | ---- | ---- | ---- |
| Net investment income | 3.49%89M | -8.51%86M | 266.67%33M | -133.33%-7M | -69.81%16M | 25.71%44M | -24.80%94M | -79.07%9M | -160.00%-3M | 10.42%53M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 0 | -99.91%3M | 0 | 0 | -99.90%3M | 0 | 85,000.00%3.4B | 0 | 9,275.00%375M | 3.02B |
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | 0 | 85.38%-37M | 67.54%-37M | -134.26%-253M | 38.04%-114M | |||||
| Less:Restructuring and mergern&acquisition | ---- | --0 | --0 | ---- | ---- | ---- | --139M | --0 | ---- | ---- |
| Less:Write off | --0 | -67.54%37M | ---- | ---- | ---- | ---- | -5.79%114M | ---- | ---- | ---- |
| Other non-operating income (expenses) | 170.97%22M | 56.34%-31M | 77.78%-8M | -9M | 185.71%6M | 28.57%-20M | -343.75%-71M | -820.00%-36M | 0 | -133.33%-7M |
| Income before tax | 23.29%5.62B | -46.82%4.56B | 855.84%736M | -61.24%1.18B | -66.76%1.43B | 6.14%1.21B | 168.38%8.57B | -83.79%77M | 250.69%3.04B | 382.75%4.31B |
| Income tax | 23.81%1.82B | -45.90%1.47B | 66.67%270M | -56.28%376M | -67.95%432M | 14.12%388M | 154.22%2.71B | -31.65%162M | 217.34%860M | 347.84%1.35B |
| Net income | 23.06%3.81B | -47.25%3.09B | 648.24%466M | -63.20%804M | -66.22%1B | 2.75%821M | 175.60%5.86B | -135.86%-85M | 266.00%2.19B | 400.51%2.96B |
| Net income continuous operations | 23.05%3.81B | -47.24%3.09B | 648.24%466M | -63.19%804M | -66.22%1B | 2.75%822M | 175.47%5.86B | -135.71%-85M | 265.83%2.18B | 400.51%2.96B |
| Noncontrolling interests | 446.51%235M | 43M | 387.50%23M | -200.00%-3M | 2,100.00%22M | -87.50%1M | 0 | 27.27%-8M | -200.00%-1M | -80.00%1M |
| Net income attributable to the company | 17.09%3.57B | -48.00%3.05B | 675.32%443M | -63.15%806M | -66.90%980M | 3.54%819M | 175.60%5.86B | -130.92%-77M | 267.56%2.19B | 403.57%2.96B |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 17.09%3.57B | -48.00%3.05B | 675.32%443M | -63.15%806M | -66.90%980M | 3.54%819M | 175.60%5.86B | -130.92%-77M | 267.56%2.19B | 403.57%2.96B |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 17.95%158.17 | -48.00%134.1 | 671.35%19.54 | -63.16%35.44 | -66.96%43.06 | 3.59%36.06 | 175.38%257.89 | -131.23%-3.42 | 267.28%96.19 | 403.32%130.31 |
| Diluted earnings per share | 17.95%158.17 | -48.00%134.1 | 671.35%19.54 | -63.16%35.4353 | -66.95%43.06 | 3.59%36.06 | 175.38%257.89 | -131.23%-3.42 | 267.28%96.19 | 403.23%130.2857 |
| Dividend per share | 63.33%49 | 46.34%30 | 52.17%17.5 | 0 | 38.89%12.5 | 0 | 10.81%20.5 | 9.52%11.5 | 0 | 12.50%9 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |